Skip to content
BYO LUX
BYO LUXBe Your Own Luxury
치료 목록
Skincare

Azelaic Acid

Naturally derived dicarboxylic acid | Brightening, anti-inflammatory, pore care

시술 시간
매일の외용 (朝・夜)
다운타임
なし
권장 횟수
지속 사용 (最低12주間推奨)

이 치료에 대해

Azelaic acid is a naturally occurring C9 dicarboxylic acid found in grains (wheat, barley, rye) with multifaceted pharmacological effects in dermatology. It inhibits tyrosinase to suppress melanin production, provides antibacterial activity (particularly against Cutibacterium acnes), anti-inflammatory effects (suppressing reactive oxygen species), and normalizes keratinization.

Prescribed at 15-20% concentration in aesthetic dermatology in Japan; FDA-approved for rosacea treatment in the West. Notable for pregnancy safety (FDA Category B). Useful as alternative therapy for patients intolerant to hydroquinone or retinoids.

작용 기전

Azelaic acid has multiple mechanisms: (1) Competitively inhibits tyrosinase, suppressing melanin synthesis in melanosomes (brightening). (2) Inhibits protein synthesis of aerobic and anaerobic bacteria, exerting direct antibacterial activity against C. acnes and Staphylococcus. (3) Functions as a scavenger of neutrophil-generated reactive oxygen species (ROS), suppressing inflammatory cascades. (4) Normalizes abnormal keratinization, preventing follicular occlusion (comedone formation). These multifaceted actions work synergistically for acne, hyperpigmentation, and rosacea.

적응증

여드름홍조·혈관 문제색소·칙칙함모공

기대 효과

Inflammatory acne reduction observed 4-8 weeks after starting 15-20% azelaic acid. Significant hyperpigmentation improvement with 12 weeks continuous use. Rosacea erythema and papules reduce at 8-12 weeks. Clinical data shows brightening efficacy comparable to 4% hydroquinone with lower irritation potential.

임상 근거

Fitton A, Goa KL (1991)
Azelaic acid: a review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs
해당 연구에서 임상적 개선이 보고되었습니다(자세한 내용은 원문 논문 참조).
Thiboutot D et al. (2003)
Efficacy and safety of azelaic acid 15% gel in the treatment of papulopustular rosacea. J Am Acad Dermatol
해당 연구에서 임상적 개선이 보고되었습니다(자세한 내용은 원문 논문 참조).
Breathnach AS (1999)
Azelaic acid: potential as a general antitumoural agent. Med Hypotheses
해당 연구에서 임상적 개선이 보고되었습니다(자세한 내용은 원문 논문 참조).
Draelos ZD et al. (2006)
A comparison of azelaic acid 20% cream and hydroquinone 4% cream for the treatment of facial hyperpigmentation. Clin Ther
해당 연구에서 임상적 개선이 보고되었습니다(자세한 내용은 원문 논문 참조).

위험 및 부작용

Mild initial irritation (stinging, itching, burning sensation) may occur but typically subsides within 2-4 weeks. Serious adverse effects extremely rare. No ochronosis risk unlike hydroquinone, enabling long-term use. Safe during pregnancy and lactation (FDA Category B).

이 치료에 관심이 있으신가요?

AI 피부 진단으로 현재 피부 상태를 확인해 보세요

AI 피부 진단 받기예약하기

다른 치료 보기

LaserPicoSure Pro자세히 보기 LaserFractional Laser자세히 보기 LaserPhotofacial IPL (Stellar M22)자세히 보기 Anti-AgingThermage FLX자세히 보기